GSK2245035: Clinical Trials

3 trials of GSK2245035, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1

Follow GSK2245035: new trials by email Literature Review of GSK2245035 trials Research Report on GSK2245035

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
GSK2245035, Placebo, FP-DPI - Asthma
Phase 2WithdrawnGlaxoSmithKline2019-01-212018-10-16
To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies
GSK2245035, Placebo - Mild Asthma and Allergic Rhinitis
Phase 2CompletedGlaxoSmithKline422013-03-012014-10-20
A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies
GSK2245035, Type 1 amber glass bottle, Placebo - Asthma and Rhinitis
Phase 2CompletedGlaxoSmithKline182012-04-012017-01-30

Conditions studied

Asthma (2)  ·  Rhinitis, Allergic (2)  ·  Rhinitis (1)

Sponsors

GlaxoSmithKline (3)

Countries

Canada (2)

Results publications

PMID 26044169